Allogenica is a biotechnology company developing an allogenic “off-the-shelf” CAR-T cells bioproduction platform. Allogenica’s ambition is to offer this next-generation cancer treatment ready to use, at low cost and safer than current treatments, in order to treat all patients in need. To know more
